Harrow • HROW
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Mark L. Baum$353.6M
Market Cap • 25/04/20242006
(há 18 anos)
2007
(17 years ago)
NASDAQ
Listagem
Nashville
Sede • Tennessee217
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
HROWSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.